Global CSR Program 2024: Seed| Takeda Pharmaceuticals
Health workforce training in Malawi, Sierra Leone, Uganda and Zambia
Building a skilled health workforce by strengthening academic and clinical programs, establishing centers of excellence, and graduating qualified health professionals ready to serve their communities
The Program
Partner: Seed Global Health
Budget: 895 million yen
Term: 5 years
Launch: 2024
Area: Malawi, Sierra Leone, Uganda and Zambia
Visit the Seed Global Health website
Sub-Saharan Africa experiences 24% of the global disease burden but has only 3% of its health workforce. With Takeda’s support, Seed Global Health will partner with Ministries of Health, academic institutions, hospitals, and health clinics to launch new academic programs in OB/GYN and neonatal emergency care, establish three locally-led centers of excellence for maternal and neonatal health, provide service training and delivery, and graduate 5,900 qualified health professionals ready to serve their communities.
The program will Improve healthcare quality through transformed, accredited training and mentorship for new qualified healthcare professionals while working with governments to strengthen health systems, enhance pandemic readiness, and promote climate resilience.
Photo Credit: Seed Global Health
Have more questions?
Contact us if you'd like more information about our Global CSR Program.
Banner Image Credit: Ezra Millstein for Mercy Corps